Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.
Saved in:
| Title: | Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study. |
|---|---|
| Authors: | Ghosh N; Levine Cancer Institute, Atrium Health, Wake Forest University School of Medicine, Charlotte, North Carolina, USA., Eyre TA; Churchill Hospital, Oxford University, Oxford, UK., Brown JR; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lamanna N; Columbia University, New York, New York, USA., Manzoor BS; AbbVie Inc., North Chicago, Illinois, USA., Coombs CC; University of California Irvine, Irvine, California, USA., Tuncer HH; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ujjani C; Fred Hutchinson Cancer Research Center, Seattle, Washington State, USA., Leslie LA; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA., Roeker LE; CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Davids MS; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rhodes JM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Skarbnik AP; Lymphoma and CLL Program, Novant Health Cancer Institute, Charlotte, North Carolina, USA., Sinai W; AbbVie Inc., North Chicago, Illinois, USA., Fleury I; Hôpital Maisonneuve-Rosemont, University of Montreal, Canada., Hill BT; Cleveland Clinic, Cleveland, Ohio, USA., Martinez-Calle N; Nottingham University Hospitals, NHS Trust, Nottingham, UK., Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA., Jawaid D; AbbVie Inc., North Chicago, Illinois, USA., Emechebe N; AbbVie Inc., North Chicago, Illinois, USA., Pearson L; University of Massachusetts, Worcester, Massachusetts, USA., Lansigan F; Dartmouth Cancer Center, Lebanon, New Hampshire, USA., Choi Y; Tufts Medical Center, Boston, Massachusetts, USA., Jensen CE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Fakhri B; Stanford Cancer Institute, Stanford University, Stanford, California, USA., Stephens DM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Marx SE; AbbVie Inc., North Chicago, Illinois, USA., Schuster SJ; University of Pennsylvania, Philadelphia, Pennsylvania, USA., Coyle M; Lowell General Hospital, Lowell, Massachusetts, USA., Pivneva I; Analysis Group Inc., Montreal, Quebec, Canada., Watson T; Analysis Group Inc., Montreal, Quebec, Canada., Guerin A; Analysis Group Inc., Montreal, Quebec, Canada., Shadman M; Fred Hutchinson Cancer Research Center, Seattle, Washington State, USA. |
| Source: | American journal of hematology [Am J Hematol] 2025 Mar; Vol. 100 (3), pp. 511-515. Date of Electronic Publication: 2024 Dec 19. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.27563 |
